US Stock MarketDetailed Quotes
CRGX CARGO Therapeutics
- 21.850
- +1.580+7.79%
Close Oct 15 16:00 ET
- 21.850
- 0.0000.00%
Post 20:01 ET
1.00BMarket Cap-6783P/E (TTM)
22.220High19.610Low335.21KVolume20.440Open20.270Pre Close7.12MTurnover1.18%Turnover RatioLossP/E (Static)45.90MShares33.92052wk High2.30P/B621.23MFloat Cap13.14052wk Low--Dividend TTM28.43MShs Float33.920Historical High--Div YieldTTM12.88%Amplitude13.140Historical Low21.242Avg Price1Lot Size
CARGO Therapeutics Key Stats
Quarterly+Annual
YOY
| (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -135.43%-35.08M | -114.36%-30.15M | -179.18%-81.16M | -155.35%-28.98M | -173.91%-23.22M | -14.9M | -14.06M | -488.26%-29.07M | -11.35M | -8.48M |
| Net income from continuing operations | -148.42%-44.35M | -180.94%-35.81M | -139.67%-98.15M | -133.30%-32.08M | -188.73%-35.47M | ---17.85M | ---12.75M | -600.02%-40.95M | ---13.75M | ---12.29M |
| Operating gains losses | ---- | ---- | -440.21%-4.14M | --0 | --0 | --0 | ---4.14M | --1.22M | --30K | --779K |
| Depreciation and amortization | 141.33%2.07M | 171.45%1.85M | 155.68%3.69M | 156.05%1.1M | 189.78%1.05M | --859K | --683K | 882.31%1.44M | --430K | --362K |
| Other non cash items | --0 | -92.95%150K | 99.70%11.89M | -73.50%720K | 421.71%8.41M | --635K | --2.13M | --5.96M | --2.72M | --1.61M |
| Change In working capital | 385.65%4.2M | 10,530.00%2.09M | -25.55%2.21M | 57.28%-346K | 65.79%1.71M | --864K | ---20K | 1,068.11%2.97M | ---810K | --1.03M |
| -Change in prepaid assets | 53.99%-582K | -140.35%-391K | 16.84%-1.59M | -168.13%-573K | 54.28%-721K | ---1.27M | --969K | -1,237.06%-1.91M | --841K | ---1.58M |
| -Change in payables and accrued expense | -29.18%4.52M | 674.39%2.8M | 48.36%9.22M | 138.03%602K | -17.58%2.73M | --6.38M | ---488K | 517.89%6.22M | ---1.58M | --3.31M |
| -Change in other current assets | 100.08%3K | 106.67%10K | -1,251.31%-3.61M | -130.85%-58K | 180.56%286K | ---3.69M | ---150K | 39.59%-267K | --188K | ---355K |
| -Change in other current liabilities | 145.49%257K | 4.27%-336K | -69.63%-1.82M | -23.83%-317K | -68.21%-582K | ---565K | ---351K | -540.72%-1.07M | ---256K | ---346K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -135.43%-35.08M | -114.36%-30.15M | -179.18%-81.16M | -155.35%-28.98M | -173.91%-23.22M | ---14.9M | ---14.06M | -488.26%-29.07M | ---11.35M | ---8.48M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 353.75%3.79M | -47,388.85%-293.96M | -173.98%-8.99M | -190.43%-2.97M | -378.55%-3.91M | -1.49M | -619K | -642.53%-3.28M | -1.02M | -816K |
| Net PPE purchase and sale | 2.01%-1.46M | -129.77%-1.29M | -203.85%-8.28M | -165.42%-2.62M | -552.08%-3.61M | ---1.49M | ---561K | -516.29%-2.72M | ---986K | ---553K |
| Net intangibles purchase and sale | -49,900.00%-500K | -468.97%-330K | -28.14%-715K | -839.47%-357K | -13.69%-299K | ---1K | ---58K | ---558K | ---38K | ---263K |
| Net investment purchase and sale | --5.75M | ---292.34M | ---- | ---- | ---- | --0 | --0 | ---- | ---- | ---- |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | 353.75%3.79M | -47,388.85%-293.96M | -173.98%-8.99M | -190.43%-2.97M | -378.55%-3.91M | ---1.49M | ---619K | -642.53%-3.28M | ---1.02M | ---816K |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 5,167,350.00%103.35M | -100.15%-104K | 1,346.78%494.58M | 2,871.00%377.91M | 1,034.47%45.1M | 2K | 71.58M | 531.42%34.19M | 12.72M | 3.98M |
| Net issuance payments of debt | --0 | --0 | -87.71%3.5M | --0 | --0 | --0 | --3.5M | --28.45M | --12.49M | --3.97M |
| Net common stock issuance | ---- | ---- | --296.61M | ---- | ---- | ---- | ---- | --0 | ---- | ---- |
| Net preferred stock issuance | --0 | --0 | 3,534.87%199.92M | --86.01M | --45.83M | --0 | --68.08M | 1.59%5.5M | --0 | --0 |
| Proceeds from stock option exercised by employees | 3,900.00%80K | --26K | -85.34%34K | -88.65%26K | 100.00%6K | --2K | --0 | --232K | --229K | --3K |
| Net other financing activities | --0 | ---130K | ---5.47M | ---4.73M | ---- | ---- | ---- | ---- | ---- | ---- |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 5,167,350.00%103.35M | -100.15%-104K | 1,346.78%494.58M | 2,871.00%377.91M | 1,034.47%45.1M | --2K | --71.58M | 531.42%34.19M | --12.72M | --3.98M |
| Net cash flow | ||||||||||
| Beginning cash position | 39.70%82.09M | 21,604.01%406.3M | 4,465.85%1.87M | 3,854.39%60.34M | 519.19%42.37M | --58.77M | --1.87M | 272.73%41K | --1.53M | --6.84M |
| Current changes in cash | 539.53%72.06M | -669.85%-324.21M | 21,987.77%404.43M | 99,886.99%345.96M | 438.03%17.97M | ---16.39M | --56.89M | 6,003.33%1.83M | --346K | ---5.32M |
| End cash Position | 263.81%154.15M | 39.70%82.09M | 21,604.01%406.3M | 21,604.01%406.3M | 3,854.39%60.34M | --42.37M | --58.77M | 4,465.85%1.87M | --1.87M | --1.53M |
| Free cash flow | -125.95%-37.05M | -116.35%-31.77M | -178.65%-90.16M | -158.25%-31.96M | -191.89%-27.12M | ---16.4M | ---14.68M | -500.93%-32.35M | ---12.37M | ---9.29M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Audit Opinions | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | -- | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data